image

CONSTED is a leading and pioneering enterprise with the most advanced international level in R&D, manufacturing and selling of large-scale crushing & screening plants , industrial milling equipments and beneficiation plants.

contact info

social networks

How Actinium Pharmaceuticals (ATNM) Stock Stands Out in a ...

Jun 12, 2020· Actinium Pharmaceuticals (ATNM) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Actinium Pharmaceuticals Highlights Analysis of Pivotal ...

Dec 04, 2018· Actinium intends to advance its Iomab-ACT program with CAR-T focused collaborators from academia and industry. Actinium's pipeline also includes a potentially best-in-class CD33 program with its ARC comprised of the anti-CD33 antibody lintuzumab …

SCK CEN And IBA Announce Partnership For Production Of ...

Sep 16, 2021· Belgian Nuclear Research Centre SCK CEN and Ion Beam Applications have formed an R&D partnership to enable the production of Actinium-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.

SCK CEN said the partnership consists of an evaluation of the technical and economic feasibility of the project. Based on the outcome of this first …

NorthStar Medical Radioisotopes and POINT Biopharma ...

Sep 08, 2021· POINT Biopharma Global Inc. is combining a portfolio of best-in-class radiopharmaceutical assets, a seasoned management team, expertise in radioisotopes such as Actinium-225 (Ac-225) and Lutetium ...

Article - Cardinal Health, TerraPower Collaborate on ...

Aug 17, 2021· By News Release. Cardinal Health and TerraPower announced an agreement to work together to develop and produce Actinium-225 for use in drug development and commercial sales. Since 2018, TerraPower has been working to increase supply of Actinium-225 from Thorium-229 decay, which is derived from legacy U.S. nuclear material.

Actinium to Highlight Expansion of Targeted Conditioning ...

Mar 11, 2021· Specific to Ac-225, Actinium has gold-standard linker technology with a strong stability and safety profile and patents covering composition of matter, formulations, methods of …

Actinium Completes Enrollment in the Pivotal Phase 3 ...

Sep 15, 2021· NEW YORK, Sept. 15, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that it has completed enrollment of the pivotal Phase 3 SIERRA trial for Iomab-B, an Antibody Radiation Conjugate (ARC) comprised of apamistamab, a CD45 targeting antibody, and the radioisotope iodine-131. The SIERRA trial is a 150 …

Actinium (NYSE:ATNM): A Story Of Delays And Promises ...

Jul 15, 2021· Actinium's top-line data from the phase 3 SIERRA trial is a few months ahead and the bad days, it appears, are behind us. Current low prices present a 'cautious' opportunity. Read more here.

Andre Louis Debierne French chemist discovered actinium ...

Andre Louis Debierne, a French chemist born on July 14, 1874 – died on August 31, 1949. Debierne was the discoverer of actinium element.Debierne in the year of 1910 in collaboration with Curie he isolated radioactive element radium while working on pitchblende.

Mining medical isotopes from nuclear waste

Jul 27, 2020· The accelerator uses a proton beam to bombard the puck, and over the course of days, generates actinium and many other fission products. That mixture of …

uses of actinium to the industry - en.rhubarbandcustard.co.za

Due to its scarcity, actinium's high cost and radioactivity means it does not have any significant industrial uses. However, it does see some use in the medical industry. Actinium's high activity level makes it a valuable element for producing neurons that are useful for radiation therapy to target and destroy cancer cells in the human body.

FDA-NRC Workshop: Enhancing Development of Targeted …

Sep 22, 2021· User and Industry Perspective . Moderator Michelle Hammond, NRC . 2:05pm - 2:25pm . Targeted Alpha Therapy (TAT) Use of Actinium-225: Regulatory Interactions Now and Tomorrow

Cardinal Health, TerraPower Collaborate on Manufacturing ...

Aug 17, 2021· Cardinal Health and TerraPower announced an agreement to work together to develop and produce Actinium-225 for use in drug development and commercial sales. Since 2018, TerraPower has been working to increase supply of Actinium-225 from Thorium-229 decay, which is derived from legacy U.S. nuclear material. Actinium-225 is an alpha-emitting ...

Thorium-228 supply ripe for research into medical ...

Aug 26, 2021· The isotope is a byproduct of actinium-227 production at ORNL that has medical uses as well. View a hi-res version of this image Summer Widner, Stephanie Timbs, James Gaugler and James Avenell of ORNL are part of a team that processes thorium-228, a byproduct of actinium-227.

Periodic Table of Elements: Actinium - Ac ...

Oct 22, 1995· Sources of Actinium: Extremely rare, found in all uranium ores. Usually obtained by treating radium with neutrons in a reactor. Total world production probably less than one gram. Uses of Actinium: Used as a source of neutrons and for thermoelectric power. Not commercially available. Additional Notes: Actinium Menu. Actinium Page One. Overview ...

TRIUMF and CNL announce first joint production run of ...

TRIUMF and Canadian Nuclear Laboratories (CNL), Canada's premier nuclear science and technology organization, are pleased to announce that they have completed the first joint production run of actinium-225, a rare medical isotope that shows great promise as the basis for new, cutting-edge cancer therapies.This accomplishment is a major milestone in making high-purity actinium-225, which is ...

Francium | History, Uses, Facts, Physical & Chemical ...

Francium was discovered by Marguerite Perey in 1939, who was studying the decay of actinium-227 by negative beta decay to an isotope of thorium and by alpha emission into an isotope of Francium-223, which was known as actinium. Dmitri Mendeleev predicted the existence of element based on the gap in the periodic table in 1870.

Implied Volatility Surging for Actinium Pharmaceuticals ...

Jul 21, 2020· Currently, Actinium Pharmaceuticals is a Zacks Rank #2 (Buy) in the Medical - Drugs industry that ranks in the Top 41% of our Zacks Industry …

ATNM: Actinium Pharmaceuticals, Inc. - 12 Month EPS ...

Oct 01, 2021· The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. An industry with a …

Uses Of Bismuth - Want to Know it

It isn't widely used in industry, but it does have some very important uses. Uses of bismuth. Bismuth is mostly used as an ingredient in pharmaceutical products. It is used to treat diarrhea and some other digestive problems and diseases. It is also added to some eye drops that are used to treat eye infections.

List of corporations that use tissue from aborted babies ...

Dec 24, 2018· List of corporations that use tissue from aborted babies in their products. Every time you purchase mass-produced processed "food" from the likes of Kraft, PepsiCo, or Nestle, you're choosing, whether you realize it or not, to feed your family not only genetically engineered poisons and chemical additives, but also various flavoring ...

PRODUCTION OF ACTINIUM-225 VIA HIGH ENERGY PROTON …

Targets will be processed at Argonne National Laboratory to separate and purify the actinium-225 that will subsequently be transferred to NorthStar laboratory facilities for product quality testing and comparison to the product quality of ORNL produced actinium-225, which is …

The Use of Fungi in the Production of Food Products

The use of the term food-making process is used here to mean those food products that require the aide of fungi in their production. For example, the one with which you are most familiar is baked bread. The yeast is utilized in making the dough rise so that bread will come out light and fluffy. Without yeast, bread would be much denser and harder.

Actinium Revenues over last 10 years from 2010 to 2021 ...

Actinium Pharmaceuticals Weighted Average Shares Diluted is relatively stable at the moment as compared to the past year. The company's current value of Weighted Average Shares Diluted is estimated at 13.09 Million.

Production of Actinium-225 via High Energy Proton Induced ...

The science of cancer research is currently expanding its use of alpha particle emitting radioisotopes. Coupled with the discovery and proliferation of molecular species that seek out and attach to tumors, new therapy and diagnostics are being developed to enhance the treatment of cancer and other diseases. This latest technology is commonly referred to as Alpha Immunotherapy (AIT). Actinium ...

Actinium Pharmaceuticals Announces The Addition of The ...

Aug 01, 2012· Actinium Pharmaceuticals, Inc. is a U.S. based biopharmaceutical company that develops innovative alpha particle immunotherapeutics based on …

TRIUMF Enters Collaboration with Fusion Pharmaceuticals to ...

Dec 18, 2020· TRIUMF Enters Collaboration with Fusion Pharmaceuticals to Boost Production of Actinium-225, a Cancer-Fighting Medical Isotope. Vancouver, BC, December 17, 2020--TRIUMF, Canada's particle accelerator centre, announced it has entered into a collaboration agreement with Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on …

Actinium Announces Multiple Senior Leadership Appointments ...

Oct 06, 2021· Dr. Diamond joins Actinium with over 20 years of experience in patent law, developing and executing IP strategy within the biotechnology industry. He …

ATNM Cash-to-Debt | Actinium Pharmaceuticals - GuruFocus.com

For the Biotechnology subindustry, Actinium Pharmaceuticals's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below: * Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot ...

Central Home Health Services of Texas Acquired By Actinium ...

Aug 2020. Region. Texas. We are pleased to announce the sale of our client, Central Home Health Services of Texas, Inc., to Actinium Healthcare Holdings, LLC. The acquisition closed August 5, 2020 and details were not disclosed. Located in Houston, Texas, Central Home Health Services of Texas (CHHS), is a licensed in-home health care agency.